SP

Shriram Parasram Kotkar

Active Director Director DIN 03615825
DIN 03615825 First appointment Sep 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2011
Shareholding value •••• Premium profile

About Shriram Parasram Kotkar

Data last updated:

Shriram Parasram Kotkar is a Director at Florentis Pharmaceuticals Private Limited (since 2011). The company operates in Pharma. Florentis Pharmaceuticals Private Limited reported revenue of ₹1.55 Cr (FY 2025).

DIN 03615825
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2011
Oldest Company Age 15 yrs
Largest company Florentis Pharmaceuticals Private Limited · ₹1.55 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Sep 20112011₹1.55 Cr (FY 2025)Active

Board colleagues of Shriram Parasram Kotkar

Directorship timeline

Open interactive timeline →
Florentis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shriram Parasram Kotkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shriram Parasram Kotkar

Shriram Parasram Kotkar currently holds 1 directorship: Florentis Pharmaceuticals Private Limited (Director, since 26 Sep 2011, revenue ₹1.55 Cr (FY 2025)).

Shriram Parasram Kotkar was first appointed on 26 Sep 2011 as Director at Florentis Pharmaceuticals Private Limited.

The current boards of Shriram Parasram Kotkar's companies include Laxman Hanmantrao Malge (Florentis Pharmaceuticals Private Limited), Vijaykumar Gangadharrao Pawar (Florentis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available